Literature DB >> 9163828

The role of imaging in staging renal adenocarcinoma.

R J Zagoria1, R E Bechtold.   

Abstract

Numerous surgical options are available to physicians treating patients with renal adenocarcinoma. In the current clinical setting, imaging plays a key role in determining which options are selected. Newer imaging techniques such as helical CT with CT angiography, MRI, and ultrasound (US) have improved staging capabilities in this patient population. However, to approach staging accuracies recently reported, attention must be paid to proper imaging parameters. This article describes the strengths, limitations, and proper techniques used for staging renal adenocarcinoma with CT, MRI, and US.

Entities:  

Mesh:

Year:  1997        PMID: 9163828     DOI: 10.1016/s0887-2171(97)90053-6

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  4 in total

Review 1.  Percutaneous ablation in the kidney.

Authors:  Aradhana M Venkatesan; Bradford J Wood; Debra A Gervais
Journal:  Radiology       Date:  2011-11       Impact factor: 11.105

Review 2.  Are bisphosphonates an indispensable tool in the era of targeted therapy for renal cell carcinoma and bone metastases?

Authors:  Daniel Keizman; Maya Ish-Shalom; Natalie Maimon; Maya Gottfried
Journal:  World J Urol       Date:  2013-03-31       Impact factor: 4.226

3.  Unique angiogenic and vasculogenic properties of renal cell carcinoma in a xenograft model of bone metastasis are associated with high levels of vegf-a and decreased ang-1 expression.

Authors:  Chao Xie; Edward M Schwarz; Erik R Sampson; Robinder S Dhillon; Dan Li; Regis J O'Keefe; Wakenda Tyler
Journal:  J Orthop Res       Date:  2011-08-01       Impact factor: 3.494

4.  Nephrectomy or nephron-sparing surgery - how to decide?

Authors:  Elżbieta Luczyńska; Sonia Dyczek; Sylwia Heinze-Paluchowska; Artur Komorowski; Tomasz Pawlik; Wojciech Wysocki; Małgorzata Klimek
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.